Application Nr Approved Date Route Status External Links
BLA125117 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Naglazyme Is Indicated For Patients With Mucopolysaccharidosis Vi (Mps Vi, Maroteaux-Lamy Syndrome). Naglazyme Has Been Shown To Improve Walking And Stair-Climbing Capacity. Naglazyme Is A Hydrolytic Lysosomal Glycosaminoglycan (Gag)-Specific Enzyme Indicated For Patients With Mucopolysaccharidosis Vi (Mps Vi; Maroteaux-Lamy Syndrome). Naglazyme Has Been Shown To Improve Walking And Stair-Climbing Capacity ( 1 ).

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Galsulfase

Comments